Global Computer Assisted Semen Analysis Market – Industry Trends and Forecast to 2030

컴퓨터 지원 정자 분석 시장 분석 및 규모

글로벌 컴퓨터 지원 정자 분석(CASA) 시장은 첨단 컴퓨터 기술을 사용하여 정자 샘플을 분석하는 데 중점을 두고 있습니다. 불임률 증가, 기술 발전, 인공 수정 기술 및 남성 불임 검사에 대한 인식 증가로 인해 크게 성장했습니다. CASA 시스템은 진단 및 치료에 도움이 되는 정자 매개변수를 정확하고 객관적으로 측정할 수 있게 해줍니다.

Data Bridge Market Research는 2022년에 4,840만 달러였던 컴퓨터 지원 정자 분석 시장이 2030년까지 5억 9,880만 달러로 급증할 것이며 예측 기간 동안 7.80%의 CAGR을 경험할 것으로 분석했습니다. 이는 시장 가치를 나타냅니다. "분석기"는 정자 분석을 위한 분석기에 대한 수요가 증가함에 따라 컴퓨터 지원 정자 분석 시장의 제품 유형 세그먼트를 지배합니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

컴퓨터 지원 정자 분석 시장 범위 및 세분화

시장 정의

컴퓨터 지원 정자 분석은 정자 분석에 사용되는 의료 기기에 컴퓨터 시스템을 통합하여 시각화 수준과 검사의 정확도를 개선하는 것을 말합니다.  

글로벌 컴퓨터 지원 정자 분석 시장 역학

운전자

• 남성 불임의 유병률 증가

전 세계적으로 증가하는 남성 불임은 CASA 시장의 주요 요인입니다. 라이프스타일 변화, 환경 오염, 연령에 따른 생식력 감소와 같은 요인으로 인해 생식력 평가를 받는 남성의 수가 증가하고 있습니다. CASA 시스템은 남성 불임을 진단하고 치료하는 데 도움이 되는 정자 매개변수에 대한 정확하고 객관적인 분석을 제공하여 시장 성장을 가속화합니다.

• CASA 기술의 발전

CASA 시스템의 기술적 발전으로 성능과 기능이 크게 향상되었습니다. 인공 지능 , 고해상도 이미징 및 고급 소프트웨어 알고리즘을 통합하여 정자 분석의 정확성, 속도 및 신뢰성이 향상되었습니다. 이러한 발전은 의료 서비스 제공자와 연구자를 끌어들여 CASA 시스템 도입을 촉진하고 시장 성장을 촉진합니다.

• 보조생식기술 도입 증가

체외수정 (IVF) 및 세포질내 정자주입(ICSI) 과 같은 ART 방법에 대한 수용 및 사용이 증가함에 따라 CASA 시스템에 대한 수요가 증가했습니다. CASA 기술은 이러한 시술을 위해 고품질 정자를 선택하여 성공적인 수정 가능성을 극대화하는 데 중요한 역할을 합니다. ART 시술이 전 세계적으로 확대됨에 따라 CASA 시스템에 대한 수요가 증가합니다.

• 의료 시설에 대한 투자 증가

의료 시설의 상태를 개선하고 전반적인 의료 인프라를 개선하는 데 대한 집중이 급증하는 것은 시장 성장을 촉진하는 또 다른 중요한 요인입니다. 자금 조달 및 새롭고 개선된 기술의 적용과 관련하여 공공 및 민간 플레이어 간의 파트너십과 전략적 협업이 증가함에 따라 수익성 있는 시장 기회가 더욱 창출되고 있습니다.

기회

• 연구 기관 및 불임 치료 병원과의 협력

Collaborating with research institutions and fertility clinics presents opportunities for CASA system manufacturers to gain insights into emerging trends, conduct clinical trials, and validate the efficacy of their products. Such collaborations can help in expanding the evidence base for CASA technology, fostering partnerships for product development, and enhancing the adoption of CASA systems in clinical practice.

• Expansion of assisted reproductive technologies

The expansion of assisted reproductive technologies, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), boosted the CASA market. CASA systems play a critical role in selecting high-quality sperm for these procedures, thereby increasing the chances of successful insemination. The increasing acceptance and adoption of ART have positively influenced the demand for CASA systems worldwide.

Restraints

• High cost of CASA systems

CASA systems are sophisticated and technologically advanced, resulting in high manufacturing and installation costs. The initial investment required for acquiring CASA systems, along with ongoing maintenance and calibration expenses, can be significant. This cost factor may limit the adoption of CASA systems, particularly in resource-constrained settings or regions with limited healthcare budgets, thereby restraining market growth.

• Limited awareness and accessibility

Despite the growing awareness of male fertility issues, individuals, healthcare providers, and even some fertility clinics still do not understand the benefits and availability of CASA technology. The limited availability of CASA systems, especially in rural or remote areas, can also be a problem. Lack of awareness and accessibility may hinder market growth as potential users may opt for traditional subjective sperm analysis methods or opt out of male fertility testing.

Challenges

• Lack of standardization

The lack of standardized protocols and guidelines for sperm analysis with CASA systems is a significant challenge. Differences in methodology, calibration and interpretation of results across systems and laboratories can lead to inconsistent and unreliable results. Standardization efforts are critical to ensure uniformity and comparability of results, which allows for better diagnosis, treatment decisions, and research outcomes.

• Limited adoption in low-resource settings

Implementation and deployment of CASA systems can be difficult in resource-poor environments, including developing countries and rural areas. Factors such as high costs, lack of infrastructure, limited technical expertise, and inadequate healthcare systems may prevent the widespread use of CASA technology. Efforts should be made to develop cost-effective and user-friendly CASA systems suitable for limited resources, as well as to train and support healthcare providers in these areas.

This computer assisted semen analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the computer assisted semen analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• There are no recent developments in the market.

Global Computer Assisted Semen Analysis Market Scope

The computer assisted semen analysis market is segmented on the basis of product type, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Analyzers
• Software
• Instruments
• Centrifuge
• Counting Chambers
• Test Kits
• Incubators
• Analyzing Disposables
• Accessories

Application

• Human
• Animal

End User

• Hospitals
• Specialty Clinics
• Research Centres
• Animal Breeding Centres
• Diagnostic Laboratories
• Fertility Centres
• Cryobanks
• Home-Care Settings
• Others

Global Computer Assisted Semen Analysis Market Regional Analysis/Insights

The computer assisted semen analysis market is analysed and market size insights and trends are provided by country, product type, application and end user, as referenced above.

The countries covered in the computer assisted semen analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the computer assisted semen analysis market due to the increased awareness of advanced fertility strategies. Furthermore, the increase in the per capita disposable income and the rising growing number of new product launches will further boost the growth of the computer assisted semen analysis market in the region during the forecast period.

Asia-Pacific is projected to observe a significant amount of growth in the computer assisted semen analysis market due to the rise in the awareness regarding accessible fertility methods. Moreover, the growing number of fertility centers and the increasing of the population's expenditures potential is further anticipated to propel the growth of the computer assisted semen analysis market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The computer assisted semen analysis market also provides you with detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for computer assisted semen analysis market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the computer assisted semen analysis market. The data is available for the historic period 2015-2020.

Competitive Landscape and Computer assisted semen analysis Market Share Analysis

The computer assisted semen analysis market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to computer assisted semen analysis market.

Some of the major players operating in the computer assisted semen analysis market are:

• Hamilton Thorne, Inc. (U.S.)
• PROiSER (Argentina)
• MICROPTIC (Spain)
• GenePro, Inc. (South Korea)
• Sperm Processor (Turkey)
• IVFSynergy (Greece)
• Kubus S.A. (Argentina)
• AKYmed Ltd (Turkey)
• Magapor SL (Spain)
• LabIVF Asia Pte Ltd. (Singapore)
• Bioline Technologies (South Africa)
• Medical Electronic Systems, LLC (U.S.)
• MMCSoft (Ukraine)
• Vitrolife (Sweden)
• Princeton BioMeditech Corporation. (U.S.)
• Sandstone Diagnostics, Inc. (U.S.)
• DiTECT-HAT (U.S.)
• DNA Diagnostic Center. (U.S.)
• CooperSurgical, Inc. (U.S.)

SKU-46524